Thyroid Function Test Market size was valued at USD 1.68 billion in 2021, and it is expected to reach a value of USD 2.56 billion by 2028, at a CAGR of more than 6.22% over the forecast period (2022- 2028).
Thyroid function tests are a series of blood tests used to assess how well the thyroid gland is functioning. This test is used to diagnose thyroid conditions like Graves' disease and Hashimoto's thyroiditis. It is used in a variety of industries, including hospitals and research laboratories. The rising number of patients suffering from thyroid disorders is expected to drive up demand for thyroid function tests. Furthermore, the growing geriatric population and increased awareness are driving the thyroid function test market, as adults are more susceptible to these disorders.
Market Overview:
Thyroid Function Test Market size was valued at USD 1.68 billion in 2021, and it is expected to reach a value of USD 2.56 billion by 2028, at a CAGR of more than 6.22% over the forecast period (2022- 2028).
Global Thyroid Function Test Market report can help you in taking the right business decisions.
Request a Free Sample Copy:
https://skyquestt.com/sample-request/thyroid-function-test-market
Top Key players operated in Global Thyroid Function Test Market:
- Thermo Fisher (US)
- Abbott (US)
- Roche (Switzerland)
- DiaSorin (Italy)
- Danaher (US)
- Kronus (US)
- Merck (Germany)
- Cortez Diagnostics (US)
- BioMérieux (France)
- Qualigen (US)
- Auto bio-Diagnostics (China)
Get Detailed Information about Global Thyroid Function Test Market:
https://skyquestt.com/report/thyroid-function-test-market
Key Offerings:
- Global Thyroid Function Test Market Size & Forecast by Revenue | 2022−2028
- Global Thyroid Function Test Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
- Market Segmentation – A detailed analysis by type, end user and region.
- Competitive Landscape – Top key vendors and other prominent vendors
Thyroid Function Test Market Recent Developments
- In February 2021, Abbott Laboratories and Roche Diagnostics made headlines recently for a study comparing their thyroid tests for subclinical hypothyroidism. The study discovered that the diagnostic results for a SCH (subclinical hypothyroidism) diagnosis using Roche's free thyroxine and TSH assays were significantly higher when compared to Abbott's thyroid assays.
Ask our analyst for more information:
https://skyquestt.com/speak-with-analyst/thyroid-function-test-market
About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.
Address:
1 Apache Way, Westford, Massachusetts 01886
Phone:
USA (+1) 617-230-0741
Email: sales@skyquestt.com
